USFDA pulls up Sun Pharma for lapses in its Gujarat plant

The US FDA warning letter to Sun Pharma summarises significant violations of Current Good Manufacturing Practice regulations for finished pharmaceuticals at the Halol plant

from The Hindu - India https://ift.tt/t1Kz7Zc